Vivos Inc (RDGL)

[rtg123]

This is how BAT-90 is prepared. It uses 2 commercially available products:

BAT-90 preparation and administration. For obtaining 1.0 ml of
BAT-90, 185 MBq (5 mCi) of 90Y microspheres (SIR-Spheres®,
Sirtex Medical, Bonn, Germany) were injected into 0.3 ml of
surgical sealant (BioGlue®, Cryolife Inc.) using a 5 ml dose syringe,
properly shielded in order to avoid possible 90Y contamination;
normal saline was added up to the final volume

Their focus is on liver and breast cancer. Mayo guided RDGL to thyroid cancer. It may take a while until there is real competition for the same tumor type.